DAaCRO - Diagnostic Research and Clinical Research Organization, Science Park of Trier, Trier, Germany.
J Altern Complement Med. 2013 Feb;19(2):161-9. doi: 10.1089/acm.2010.0636. Epub 2012 Sep 10.
Stress impacts on health, causing stress-related illness. The aim of this study was to investigate stress dampening effects of the homeopathic combination remedy dysto-loges(®) S on physiological and psychological measures during acute stress. Additionally, effects of the substance on sleep and life quality were investigated.
This randomized, double-blind, placebo-controlled single center study had a total duration of 15 days for each participant.
SETTING/LOCATION: The study was performed by Daacro, Trier, Germany.
We included 40 women aged 30-50 years that regularly experienced impaired well-being when feeling stressed.
Participants took three tablets daily for 14 days. On the final study day, participants took three pills in the morning and upon arrival at the study site. Thereafter, the Trier Social Stress Test (TSST) was performed.
Primary endpoints were saliva cortisol responses to the stress test. Secondary biological endpoints were plasma cortisol, adrenocorticotrophic hormone, epinephrine, and norepinephrine (NE) and heart rates. Psychological secondary endpoints were well-being, anxiety, stress, and insecurity during the stress test as well as sleep and quality of life.
Stress-induced cortisol levels did not differ between groups, but verum-treated participants were characterized by lower NE levels. Two weeks of treatment with the homeopathic substance resulted in a better sleep quality. Sleep improvement was associated with a higher hormonal response to the TSST in both groups. In addition, individuals with impaired sleep in the placebo group had higher unstimulated NE levels.
This study provides preliminary evidence for beneficial effects of dysto-loges S on sleep quality. Improvement of sleep quality was positively associated with a normalized neuroendocrine stress response during acute stress, whereas an altered hormonal response was observed in participants with impaired sleep. We hypothesize that the test product may possibly reduce NE release.
压力对健康有影响,会导致与压力相关的疾病。本研究旨在调查顺势疗法组合药物 dysto-loges(®)S 对急性应激下生理和心理指标的应激缓解作用。此外,还研究了该物质对睡眠和生活质量的影响。
这是一项随机、双盲、安慰剂对照的单中心研究,每个参与者的总研究时间为 15 天。
该研究由德国特里尔的 Daacro 进行。
我们纳入了 40 名年龄在 30-50 岁之间的女性,她们在感到压力时经常出现健康状况受损。
参与者每天服用三片,持续 14 天。在最后一天的研究中,参与者在早上和到达研究地点时服用三片药丸。之后,进行特里尔社会应激测试(TSST)。
主要终点是唾液皮质醇对压力测试的反应。次要生物学终点是血浆皮质醇、促肾上腺皮质激素、肾上腺素和去甲肾上腺素(NE)以及心率。心理次要终点是在压力测试期间的幸福感、焦虑、压力和不安全感,以及睡眠和生活质量。
两组之间应激诱导的皮质醇水平没有差异,但真药组的 NE 水平较低。用顺势疗法物质治疗两周可改善睡眠质量。在两组中,睡眠改善与 TSST 应激反应的激素水平升高相关。此外,安慰剂组中睡眠障碍的个体在未受刺激时的 NE 水平较高。
这项研究提供了初步证据,表明 dysto-loges S 对睡眠质量有有益的影响。睡眠质量的改善与急性应激期间神经内分泌应激反应的正常化呈正相关,而睡眠障碍的个体观察到激素反应改变。我们假设测试产品可能会减少 NE 的释放。